| 注册
首页|期刊导航|国际生殖健康/计划生育杂志|产科抗磷脂综合征诊治现状

产科抗磷脂综合征诊治现状

李彦林 何银芳

国际生殖健康/计划生育杂志2024,Vol.43Issue(3):254-259,6.
国际生殖健康/计划生育杂志2024,Vol.43Issue(3):254-259,6.DOI:10.12280/gjszjk.20240073

产科抗磷脂综合征诊治现状

Progress in the Diagnosis and Treatment of Obstetric Antiphospholipid Syndrome

李彦林 1何银芳2

作者信息

  • 1. 030000 太原,山西医科大学第一临床医学院
  • 2. 山西医科大学第一医院产科
  • 折叠

摘要

Abstract

Obstetric antiphospholipid syndrome(OAPS)is an autoimmune disease characterized by persistent positivity of antiphospholipid antibody(aPL)and pathological pregnancy,with clinical manifestations such as recurrent spontaneous abortion,fetal death,fetal growth restriction,preeclampsia,and premature delivery.Early diagnosis and appropriate management of the patients with OAPS can significantly reduce the incidence of pregnancy complications.Currently,the first-line therapeutic option is aspirin combined with low molecular weight heparin,which improves the pregnancy outcome in most patients.The second-line therapeutic medications,such as hydroxychloroquine and glucocorticoid,can be used as a complement to the first-line therapeutic option.The emerging therapeutic medications,such as biologics and statins,are still at the exploratory stage of clinical application.In this article,we review the advances in the diagnosis and treatment of OAPS.

关键词

抗磷脂综合征/妊娠/抗体,抗磷脂/诊断/治疗/阿司匹林/肝素,低分子量

Key words

Antiphospholipid syndrome/Pregnancy/Antibodies,antiphospholipid/Diagnosis/Therapy/Aspirin/Heparin,low-molecular-weight

引用本文复制引用

李彦林,何银芳..产科抗磷脂综合征诊治现状[J].国际生殖健康/计划生育杂志,2024,43(3):254-259,6.

国际生殖健康/计划生育杂志

OACSTPCD

1674-1889

访问量0
|
下载量0
段落导航相关论文